SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-014034
Filing Date
2020-09-30
Accepted
2020-09-30 16:09:21
Documents
9
Period of Report
2020-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k093020.htm 8-K 45538
2 EX-1.1 ex11crdf093020.htm EX-1.1 347023
3 EX-5.1 ex51crdf093020.htm EX-5.1 26193
4 EX-99.1 ex991crdf093020.htm EX-99.1 14493
5 EX-99.2 ex992crdf093020.htm EX-99.2 14374
6 cardifflogorgbtm1.jpg GRAPHIC 176318
7 image01.jpg GRAPHIC 288
8 image011.jpg GRAPHIC 50931
9 image03.jpg GRAPHIC 50931
  Complete submission text file 0001628280-20-014034.txt   817879
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 201212355
SIC: 2836 Biological Products, (No Diagnostic Substances)